Africa: BluePeak impact investment of up to US$15m supports Africure’s Africa strategy

Alternative asset management firm, BluePeak Private Capital, has announced an investment of up to US$15m in Africure, a pan-African manufacturer and distributor of pharmaceutical goods. The investment provides a vital working capital boost to Africure as it faces increased demand for pharmaceutical goods across its more than 10 African markets. Founded in 2017, Africure Pharmceutical,…

You must be a HMI Subscriber to view this content.

Subscribe Now »